Boston Scientific Corp. (BSX) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $47.80 +1.81%
Revenue Growth %: +3.7%
Financial Fact:
Interest expense: -58M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.7%
Financial Fact:
Interest expense: -58M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Boston Scientific Corp. (NYSE: BSX) reported Q2 EPS of $0.18, $0.01 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $1.87 billion versus the consensus estimate of $1.87 billion.
For earnings history and earnings-related data on Boston Scientific Corp. (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
- Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
